Navigation Links
Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
Date:1/20/2012

BOULDER, Colo. and PORTLAND, Ore., Jan. 20, 2012 /PRNewswire/ -- Boulder Diagnostics Inc. and Portland State University (PSU) announced today the entry into a license and collaboration agreement to develop rapid diagnostic tests for homocysteine and related compounds based on a highly specific dye technology developed at PSU. Under the agreement Boulder will finance further research at the Department of Chemistry, and PSU will be entitled to royalties on future sales of the licensed technology. Further details were not disclosed.

The innovative and highly specific dye technology developed in the laboratory of Prof. Robert Strongin at PSU enables the development of rapid diagnostic tests for homocysteine and related compounds. The new dye technology will be used in medical tests to help determine indicators for a variety of diseases, including cancer, Alzheimer's, Parkinson's, cystic fibrosis, and HIV.

"The groundbreaking technology of Prof. Strongin and his team can form the basis for a new line of products," says Wolfgang Pieken, CEO of Boulder Diagnostics Inc.

"We are excited to adapt our innovative detection chemistry to rapid diagnostic tests with Boulder Diagnostics," comments Robert Strongin, Professor of Chemistry at Portland State University.

Editor's note

For further information, please contact:

Boulder Diagnostics: Wolfgang Pieken, CEO
6395 Gunpark Drive, Ste W - Boulder, CO 80301
Phone: 720.897.6276 - info@boulderdiagnostics.com
http://www.boulderdiagnostics.com

Portland State University: Joseph Janda, Director of Innovation & Intellectual Property
PO Box 751 - Portland, OR 97207-0751
Phone: 503.725.8454 - iia@pdx.edu
http://www.pdx.edu

About Boulder Diagnostics

Boulder Diagnostics Inc. provides new diagnostic solutions to undeserved or underperforming disease diagnostics areas. It currently markets novel specific antibody reagents for the diagnosis of parasite infections.

About Portland State University (PSU)

Located in Portland, Oregon, PSU has about 30,000 undergraduate and graduate students. PSU's motto is "Let Knowledge Serve the City," and it provides every student with opportunities to work with businesses, schools and organizations on real-world projects. Its downtown campus exhibits PSU's commitment to sustainability through green buildings and business practice. Sustainability is incorporated into much of PSU's curriculum.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Boulder Diagnostics Inc.; Portland State University
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CU-Boulder python study may have implications for human heart health
2. Novel CU-Boulder technique shrinks size of nanotechnology circuitry
3. Ultrafast lasers give CU-Boulder researchers a snapshot of electrons in action
4. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
5. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
8. S.E.D. Labs to be Acquired by Quest Diagnostics
9. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... MANHASSET, N.Y. , Jan. 16, 2017   ... Kevin J. Tracey, MD , president and CEO of ... Northwell Health, completed an analysis of how the nervous ... further identify and develop bioelectronic medicine devices ... today in Nature Neuroscience . The ...
(Date:1/14/2017)... Jan. 13, 2017  The Alliance for Safe Biologic ... to FDA final guidance on biologic naming: ... leadership in emphasizing the importance of distinct naming for ... of the benefits biosimilars will bring to patients, including ... Yet the portion of the Guidance dealing with suffix ...
(Date:1/13/2017)... , ... January 13, 2017 , ... ... cuvette-related demand that it has found among its diverse customer base. The latest ... use in most brands electroporators including BTX and Bio-Rad. FireflySci is introducing three ...
(Date:1/12/2017)... (PRWEB) , ... January 12, ... ... disposable devices with short response times capable of performing routine electrochemical biosensing ... disposable screen-printed electrodes provide fast, sensitive detection and quantification of various analytes ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, 2016 ... financial services provider, today announced an agreement with NuData Security, ... to join forces. The partnership will enable clients to focus ... compliance with local data protection regulation. ... In order to provide a ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
Breaking Biology News(10 mins):